Cited by 342Monoclonal and Polyclonal Antibodies ResearchProtein Structure and Dynamicsvaccines and immunoinformatics approaches

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Computational design of antibody-affinity improvement beyond in vivo maturation

Open access

Lippow, Shaun M, Wittrup, K Dane, Tidor, Bruce·2007·Nature Biotechnology

DOI 10.1038/nbt1336PMC PMC2803018

Open this paper in CoChat — free account

Abstract

Antibodies are used extensively in diagnostics and as therapeutic agents. Achieving high-affinity binding is important for expanding detection limits, extending dissociation half-times, decreasing drug dosages and increasing drug efficacy. However, antibody-affinity maturation in vivo often fails to produce antibody drugs of the targeted potency, making further affinity maturation in vitro by directed evolution or computational design necessary. Here we present an iterative computational design procedure that focuses on electrostatic binding contributions and single mutants. By combining multiple designed mutations, a tenfold affinity improvement to 52 pM was engineered into the anti-epidermal growth factor receptor drug cetuximab (Erbitux), and a 140-fold improvement in affinity to 30 pM was obtained for the anti-lysozyme model antibody D44.1. The generality of the methods was further demonstrated through identification of known affinity-enhancing mutations in the therapeutic antibody bevacizumab (Avastin) and the model anti-fluorescein antibody 4-4-20. These results demonstrate computational capabilities for enhancing and accelerating the development of protein reagents and therapeutics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nbt1336

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Computational Design of a Biologically Active Enzyme
Dwyer, M. A., Looger, L. L., & Hellinga, H. W. (2004) · Science · doi:10.1126/science.1098432 · Cited by 295
Retracted
Design of a Novel Globular Protein Fold with Atomic-Level Accuracy
Kuhlman, B. A., Dantas, G. A., Ireton, G. C., Varani, G., Stoddard, B. L., & Baker, D. A. (2003) · Science · doi:10.1126/science.1089427 · Cited by 1,666
Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.
Presta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., KRUMMEN, L. A., Winkler, M., & Ferrara, N. (1997) · PubMed · Cited by 1,596
De Novo Protein Design: Fully Automated Sequence Selection
Dahiyat, B. I., & Mayo, S. L. (1997) · Science · doi:10.1126/science.278.5335.82 · Cited by 1,156
Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity
Boder, E. T., Midelfort, K. S., & Wittrup, K. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170297297 · Cited by 673
Self-citation
Computational design of receptor and sensor proteins with novel functions
Looger, L. L., Dwyer, M. A., Smith, J. J., & Hellinga, H. W. (2003) · Nature · doi:10.1038/nature01556 · Cited by 668
Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.
Sato, J. D., Kawamoto, T., Le, A. D., Mendelsohn, J. M., Polikoff, J., & SATO, G. H. (1983) · PubMed · Cited by 458
Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. Wilson
Chen, Y., Wiesmann, C., Fuh, G., Li, B., Christinger, H. W., McKay, P., de Vos, A. M., & Lowman, H. B. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3192 · Cited by 449
Kinetic and affinity limits on antibodies produced during immune responses.
Foote, J., & Eisen, H. N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1254 · Cited by 375
Computational Thermostabilization of an Enzyme
Korkegian, A., Black, M. E., Baker, D. A., & Stoddard, B. L. (2005) · Science · doi:10.1126/science.1107387 · Cited by 360

Show all 30 references

Sorted by citations

Items 201–300 of 340

Structure-guided mutations in CDRs for enhancing the affinity of neutralizing SARS-CoV-2 nanobody
Singh, V., Bhutkar, M., Choudhary, S., Nehul, S., Kumar, R., Singla, J., Kumar, P., & Tomar, S. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150746 · Cited by 14
Non-H3 CDR template selection in antibody modeling through machine learning
Long, X., Jeliazkov, J. R., & Gray, J. J. (2019) · PeerJ · doi:10.7717/peerj.6179 · Cited by 14
The effect of mutations on binding interactions between the SARS-CoV-2 receptor binding domain and neutralizing antibodies B38 and CB6
Barnes, J. E., Lund-Andersen, P. K., Patel, J. S., & Ytreberg, F. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-23482-5 · Cited by 12
Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design
Holt, G. T., Gorman, J., Wang, S., Lowegard, A. U., Zhang, B., Liu, T. W. B., Lin, B. C., Louder, M. K., Frenkel, M. S., McKee, K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112711 · Cited by 13
Revolutionizing Synthetic Antibody Design: Harnessing Artificial Intelligence and Deep Sequencing Big Data for Unprecedented Advances
Gallo, E. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01064-2 · Cited by 17
Protein side-chain modeling with a protein-dependent optimized rotamer library
Francis‐Lyon, P., & Koehl, P. (2014) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24555 · Cited by 13
QM/MM Description of Newly Selected Catalytic Bioscavengers Against Organophosphorus Compounds Revealed Reactivation Stimulus Mediated by Histidine Residue in the Acyl-Binding Loop
Zlobin, A. S., Mokrushina, Y. A., Terekhov, S. S., Zalevsky, A. O., Bobik, T. V., Stepanova, A. V., Aliseychik, M., Kartseva, O. V., Panteleev, S. V., Golovin, A. V., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00834 · Cited by 13
Computer-guided library generation applied to the optimization of single-domain antibodies
Akiba, H., Tamura, H., Caaveiro, J. M. M., & Tsumoto, K. (2019) · Protein Engineering Design and Selection · doi:10.1093/protein/gzaa006 · Cited by 13
Molecular Dynamics Simulation for Investigating Antigen–Antibody Interaction
Yamashita, T. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2609-2_4 · Cited by 12
AbDesign: database of point mutants of antibodies with associated structures reveals poor generalization of binding predictions from machine learning models
Janusz, B., Chomicz, D., Demharter, S., Arts, M., de Kanter, J. K., Wilke, Y., Britze, H., Wrobel, S., Gawłowski, T., Dudzic, P., et al. (2025) · mAbs · doi:10.1080/19420862.2025.2567319 · Cited by 13
Designing electrostatic interactions in biological systems via charge optimization or combinatorial approaches: insights and challenges with a continuum electrostatic framework
Radhakrishnan, M. L. (2012) · Theoretical Chemistry Accounts · doi:10.1007/s00214-012-1252-5 · Cited by 12
Matched Peptides: Tuning Matched Molecular Pair Analysis for Biopharmaceutical Applications
Fuchs, J. E., Wellenzohn, B., Weskamp, N., & Liedl, K. R. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00476 · Cited by 12
In Silico Engineering Towards Enhancement of Bap–VHH Monoclonal Antibody Binding Affinity
Sefid, F., Payandeh, Z., Azamirad, G., Abdolhamidi, R., & Rasooli, I. (2018) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-017-9670-9 · Cited by 12
Fc‐Binding Antibody‐Recruiting Molecules Targeting Prostate‐Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement**
Sasaki, K., Harada, M., Yoshikawa, T., Tagawa, H., Harada, Y., Yonemitsu, Y., Ryujin, T.-A., Kishimura, A., Mori, T., & Katayama, Y. (2020) · ChemBioChem · doi:10.1002/cbic.202000577 · Cited by 12
Incorporating receptor flexibility in the molecular design of protein interfaces
Li, L., Liang, S., Pilcher, M. M., & Meroueh, S. O. (2009) · Protein Engineering Design and Selection · doi:10.1093/protein/gzp042 · Cited by 12
Cell Surface Display Systems For Protein Engineering
Cochran, J. R., Moore, S. J., Cochran, F. V., & Olsen, M. J. (2009) · CRC Press eBooks · doi:10.1201/9781420076592.ch2 · Cited by 11
Development of a potent high-affinity human therapeutic antibody via novel application of recombination signal sequence–based affinity maturation
Kielczewska, A., D’Angelo, I., Amador, M. S., Wang, T., Sudom, A. M., Min, X., Rathanaswami, P., Pigott, C. R., & Foltz, I. N. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101533 · Cited by 11
Antibody-Based Biosensors
Dzantiev, B. B., & Zherdev, A. V. (2013) · Series in sensors · doi:10.1201/b15589-7 · Cited by 11
Unraveling the Tomaralimab Epitope on the Toll-like Receptor 2 via Molecular Dynamics and Deep Learning
Ahmad, S. B., & Choi, S. (2022) · ACS Omega · doi:10.1021/acsomega.2c02559 · Cited by 11
Yeast Display-Based Antibody Affinity Maturation Using Detergent-Solubilized Cell Lysates
Tillotson, B. J., Lajoie, J. M., & Shusta, E. V. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2748-7_4 · Cited by 11
RosettaAntibodyDesign (RAbD): A General Framework for Computational Antibody DesignPreprint
Adolf-Bryfogle, J., Kalyuzhniy, O., Kubitz, M., Weitzner, B. D., Hu, X., Adachi, Y., Schief, W. R., & Dunbrack, R. L. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/183350 · Cited by 11
Macromolecules and Antibody-Based Drugs
Su, X., & Yao, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3266-5_20 · Cited by 11
Combinations of Affinity-Enhancing Mutations in a T Cell Receptor Reveal Highly Nonadditive Effects within and between Complementarity Determining Regions and Chains
Pierce, B. G., Haidar, J. N. S., Yu, Y., & Weng, Z. (2010) · Biochemistry · doi:10.1021/bi901969a · Cited by 10
Computer-Aided Antibody Design: An Overview
Choong, Y. S., Lee, Y. V., Soong, J. X., Law, C. T., & Lim, Y. Y. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-72077-7_11 · Cited by 10
Emerging technologies in protein interface engineering for biomedical applications
Krohl, P. J., Ludwig, S. D., & Spangler, J. B. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.01.017 · Cited by 10
Comparative Protein Structure Modelling
Fiser, A. (2017) · Springer eBooks · doi:10.1007/978-94-024-1069-3_4 · Cited by 11
Achievements and Challenges in Computational Protein Design
Samish, I. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6637-0_2 · Cited by 9
An antibody engineering platform using amino acid networks: A case study in development of antiviral therapeutics
Lee, D. C. P., Raman, R., Ghafar, N. A., & Budigi, Y. (2021) · Antiviral Research · doi:10.1016/j.antiviral.2021.105105 · Cited by 8
Characterizing the morphology of protein binding patches
Malod‐Dognin, N., Bansal, A., & Cazals, F. (2012) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24144 · Cited by 9
The Framework of Computational Protein Design
Samish, I. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6637-0_1 · Cited by 9
Connecting the sequence dots: shedding light on the genesis of antibodies reported to be designed in silico
Vásquez, M., Krauland, E. M., Walker, L. M., Wittrup, K. D., & Gerngross, T. U. (2019) · mAbs · doi:10.1080/19420862.2019.1611172 · Cited by 9
Self-citation
AntBO: Towards Real-World Automated Antibody Design with Combinatorial Bayesian OptimisationPreprint
Khan, A., Cowen-Rivers, A. I., Deik, D.-G.-X., Grosnit, A., Robert, P. A., Greiff, V., Smorodina, E., Rawat, P., Akbar, R., Dreczkowski, K., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4115860 · Cited by 9
In Silico Maturation of a Nanomolar Antibody against the Human CXCR2
Buratto, D., Wan, Y., Shi, X., Yang, G., & Zonta, F. (2022) · Biomolecules · doi:10.3390/biom12091285 · Cited by 8
Computational Design of Protein-Based Inhibitors of Plasmodium vivax Subtilisin-Like 1 Protease
Bastianelli, G., Bouillon, A., Nguyen, C., Le‐Nguyen, D., Nilges, M., & Barale, J.-C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109269 · Cited by 8
Engineering Protein Therapeutics: Predictive Performances of a Structure-Based Virtual Affinity Maturation Protocol
Oberlin, M., Kroemer, R. T., Mikol, V., Minoux, H., Tastan, E., & Baurin, N. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3001474 · Cited by 8
Design and construction of small perturbation mutagenesis libraries for antibody affinity maturation using massive microchip-synthesized oligonucleotides
Xu, M., Hu, S., Ding, B., Fei, C., Wan, W., Hu, D., Du, R., Zhou, X., Hong, J., Liu, H., et al. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.11.007 · Cited by 8
Multi Epitope-Targeting Immunoprecipitation Using F(ab′) Fragments with High Affinity and Specificity for the Enhanced Detection of a Peptide with Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry
Kaneko, N., Yoshimori, T., Yamamoto, R., Capon, D. J., Shimada, T., Sato, T., & Tanaka, K. (2013) · Analytical Chemistry · doi:10.1021/ac303344h · Cited by 8
Synthetic peptides mimicking the binding site of human acetylcholinesterase for its inhibitor fasciculin 2
Kafurke, U., Erijman, A., Aizner, Y., Shifman, J. M., & Eichler, J. (2015) · Journal of Peptide Science · doi:10.1002/psc.2797 · Cited by 8
Evaluation of an inverse molecular design algorithm in a model binding site
Huggins, D. J., Altman, M. D., & Tidor, B. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22226 · Cited by 8
Self-citation
Structure-based design and discovery of novel anti-tissue factor antibodies with cooperative double-point mutations, using interaction analysis
Chiba, S., Tanabe, A., Nakakido, M., Okuno, Y., Tsumoto, K., & Ohta, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-74545-4 · Cited by 8
Therapeutic Antibodies and Other Proteins Obtained by Molecular Display Technologies
Shibasaki, S., & Ueda, M. (2009) · Recent Patents on Biotechnology · doi:10.2174/187220809787172641 · Cited by 8
Affinity Improvement of a Humanized Antiviral Antibody by Structure-Based Computational Design
Farhadi, T., Fakharian, A., & Hashemian, S. M. (2017) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-017-9660-y · Cited by 7
Rosetta:MSF:NN: Boosting performance of multi-state computational protein design with a neural network
Nazet, J., Lang, E. W., & Merkl, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256691 · Cited by 6
Designing and bioengineering of CDRs with higher affinity against receptor-binding domain (RBD) of SARS-CoV-2 Omicron variant
Singh, V., Choudhary, S., Bhutkar, M., Nehul, S., Ali, S., Singla, J., Kumar, P., & Tomar, S. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138751 · Cited by 7
Predicting interfacial hot-spot residues that stabilize protein-protein interfaces in oligomeric membrane-toxin pores through hydrogen bonds and salt bridges
Desikan, R., Maiti, P. K., & Ayappa, K. G. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1711806 · Cited by 8
Affinity-matured variants derived from nimotuzumab keep the original fine specificity and exhibit superior biological activity
Tundidor, Y., Ponce, L. F., Chao, L., Solozabal, J., Hust, M., Dübel, S., & Rojas, G. (2020) · Scientific Reports · doi:10.1038/s41598-019-57279-w · Cited by 7
Amino acid interaction networks provide a new lens for therapeutic antibody discovery and anti-viral drug optimization
Viswanathan, K., Shriver, Z. H., & Babcock, G. J. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.03.019 · Cited by 7
In silico Techniques for Prospecting and Characterizing Monoclonal Antibodies
Manieri, T. M., Magalhães, C. G., Takata, D. Y., Batalha-Carvalho, J. V., & Moro, A. M. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.94366 · Cited by 8
Proven in vitro evolution of protease cathepsin E‐inhibitors and ‐activators at pH 4.5 using a paired peptide method
Kitamura, K., Komatsu, M., Biyani, M., Futakami, M., Kawakubo, T., Yamamoto, K., & Nishigaki, K. (2012) · Journal of Peptide Science · doi:10.1002/psc.2453 · Cited by 7
Antibody Engineering: Humanization, Affinity Maturation, and Selection Techniques
Almagro, J. C., & Strohl, W. R. (2009) · Wiley eBooks · doi:10.1002/9780470485408.ch13 · Cited by 8
Evaluation of Methods for Protein Representation Learning: A Quantitative AnalysisPreprint
Ünsal, S., Ataş, H., Albayrak, M., Turhan, K., Acar, A. C., & Doğan, T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.28.359828 · Cited by 7
Redesigning an antibody H3 loop by virtual screening of a small library of human germline-derived sequences
Corbeil, C. R., Manenda, M. S., Sulea, T. I., Baardsnes, J., Picard, M.-È., Hogues, H., Gaudreault, F., Deprez, C., Shi, R., & Purisima, E. O. (2021) · Scientific Reports · doi:10.1038/s41598-021-00669-w · Cited by 7
Investigation of major amino acid residues of anti-norfloxacin monoclonal antibodies responsible for binding with fluoroquinolones
Boonserm, P., Puthong, S., Wichai, T., Noitang, S., Khunrae, P., Sooksai, S., & Komolpis, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-96466-6 · Cited by 6
Machine learning modeling to identify affinity improved biobetter anticancer drug trastuzumab and the insight of molecular recognition of trastuzumab towards its antigen HER2
Balakrishnan, N., Baskar, G., Balaji, S., Kullappan, M., & Surapaneni, K. M. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1961866 · Cited by 6
Molecular Dynamics Simulation of the Antigen–Antibody Complex Formation Process between Hen Egg-White Lysozyme and HyHEL-10
Takamatsu, Y., Hamakubo, T., & Yamashita, T. (2022) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20220239 · Cited by 6
The validation of artificial anti‐monkeypox antibodies by in silico and experimental approaches
Shabani, S., Rashidi, M., Radgoudarzi, S., & Jebali, A. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.834 · Cited by 6
Combining different design strategies for rational affinity maturation of the MICA‐NKG2D interface
Henager, S. H., Hale, M. A., Maurice, N. J., Dunnington, E. C., Swanson, C. J., Peterson, M. J., Ban, J. J., Culpepper, D. J., Davies, L. D., Sanders, L. K., et al. (2012) · Protein Science · doi:10.1002/pro.2115 · Cited by 6
Direct Calculation of Protein Fitness Landscapes through Computational Protein Design
Au, L., & Green, D. F. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2015.11.029 · Cited by 6
Analysis of interleukin 23 and 7G10 interactions for computational design of lead antibodies against immune-mediated inflammatory diseases
Khan, N. S., Verma, R., Pradhan, D., Nayek, A., Bhuyan, R., Sahu, T. K., & Jain, A. K. (2018) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2018.1511729 · Cited by 6
Computational Protein Design for Synthetic Biology
Richter, F. M., & Baker, D. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394430-6.00006-6 · Cited by 6
Computational protein design: Advancing biotechnology through in silico engineering
Ranbhor, R. S., Venkatesan, R., Redkar, A. S., & Ramakrishnan, V. (2025) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2025.07.003 · Cited by 6
Progress toward new function and design of extracellular G protein-coupled receptor nanobodies
Schlimgen, R. R., & Volkman, B. F. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100054 · Cited by 5
Affinity enhancement of HER2-binding Z(HER2:342) affibody via rational design approach: a molecular dynamics study
Ghaffari, M. A., Zeinali, M., Barzegari, E., Jamalan, M., & Jahandideh, S. S. (2013) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2013.842499 · Cited by 5
Affinity Maturation Approaches for Antibody Lead Optimization
Lowe, D., Wilkinson, T. C. I., & Vaughan, T. J. (2011) · Modecular medicine and medicinal · doi:10.1142/9781848166295_0003 · Cited by 5
Homology Modeling of Antibody Variable Regions: Methods and Applications
Bansia, H., & Ramakumar, S. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2974-1_16 · Cited by 5
An optimized thermodynamics integration protocol for identifying beneficial mutations in antibody design
Sheng, Z., Bimela, J. S., Wang, M., Li, Z., Guo, Y., & Ho, D. D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1190416 · Cited by 5
Antibody Engineering for Biosensor Applications
Hopkins, N. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0919-0_12 · Cited by 5
Expanded Explorations into the Optimization of an Energy Function for Protein Design
Huang, Y.-M., & Bystroff, C. (2013) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2013.113 · Cited by 5
Charged Residue Implantation Improves the Affinity of a Cross-Reactive Dengue Virus Antibody
Wei, H., Tan, J., Zhou, B., Guan, X., Zhong, Q., & Wang, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084197 · Cited by 4
Combining computational modeling and experimental library screening to affinity‐mature VEEV ‐neutralizing antibody F5
Sumner, C. A., Schwedler, J. L., McCoy, K. M., Holland, J., Duva, V., Gelperin, D. M., Busygina, V., Stefan, M. A., Martinez, D. V., Juarros, M. A., et al. (2025) · Protein Science · doi:10.1002/pro.70043 · Cited by 3
4.14 Rational and Combinatorial Methods to Create Designer Protein Interfaces ☆
Park, S. J., Lui, B. H., & Cochran, J. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.10152-3 · Cited by 4
Therapeutic antibody discovery
Hoover, J. M., Prinslow, E. G., Teigler, J. E., Truppo, M. D., & LaPorte, S. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820007-0.00023-4 · Cited by 4
Antibodies: Computer-Aided Prediction of Structure and Design of Function
Sevy, A. M., & Meiler, J. (2015) · ASM Press eBooks · doi:10.1128/9781555817411.ch10 · Cited by 4
Binding of Proteins to Copolymers of Varying Charges and Hydrophobicity: A Molecular Mechanism and Computational Strategies
Xu, X., Zhang, T., Angioletti‐Uberti, S., & Lv, Y. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00521 · Cited by 4
Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against broad-spectrum neutralizing antibodies through epitopes mapping
Shah, M., & Woo, H. G. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1236617 · Cited by 4
Interactions between anti-ErbB2 antibody A21 and the ErbB2 extracellular domain provide a basis for improving A21 affinity
Chang, L., Zhou, C., Xu, M., & Liu, J. L. (2009) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-009-9312-1 · Cited by 4
Biophysics of SARS-CoV-2 spike protein’s receptor-binding domain interaction with ACE2 and neutralizing antibodies: from computation to functional insights
da Silva, F. L. B., Paco, K., Laaksonen, A., & Ray, A. (2025) · Biophysical Reviews · doi:10.1007/s12551-025-01276-z · Cited by 5
Exploring objective functions and cross-terms in the optimization of an energy function for protein design
Huang, Y.-M., & Bystroff, C. (2012) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/2382936.2382956 · Cited by 3
Protein Structure Prediction and Homology Modeling
Leach, A. R., & Thomas, P. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12350-9 · Cited by 4
A Novel Human Antibody, HF, against HER2/erb-B2 Obtained by a Computer-Aided Antibody Design Method
Qiao, C., Lv, M., Li, X., Lang, X., Lv, S., Long, M., Li, Y., Geng, S., Zhou, L., Shen, B., et al. (2021) · Engineering · doi:10.1016/j.eng.2020.10.024 · Cited by 3
Development of an integrated structural biology platform specialized for sub-100 kDa protein complexes to support biologics discovery and rational engineering
Iozzo, Y., Svidritskiy, E., Qiu, Y., Xu, A., Park, A., Wendt, M., & Zhou, Y. (2021) · Antibody Therapeutics · doi:10.1093/abt/tbab025 · Cited by 3
Structure-Based Affinity Maturation of Antibody Based on Double-Point Mutations
Chiba, S., Okuno, Y., & Ohta, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2609-2_18 · Cited by 3
Analytical Method for Experimental Validation of Computer-Designed Antibody
Tanabe, A., & Tsumoto, K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2609-2_23 · Cited by 3
Antibody designing against IIIabc junction (JIIIabc) of HCV IRES through affinity maturation; RNA-Antibody docking and interaction analysis
Ejaz, S., Paracha, R. Z., Ejaz, S., & Jamal, Z. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291213 · Cited by 3
Optimizing Antibody–Antigen Binding Affinities with the ADAPT Platform
Sulea, T. I., Deprez, C., Corbeil, C. R., & Purisima, E. O. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2609-2_20 · Cited by 3
Engineering Antibodies and Alternative Binders for Therapeutic Uses
Aoki, W. (2019) · Springer eBooks · doi:10.1007/978-981-13-5868-5_10 · Cited by 3
Thermodynamic analyses of amino acid residues at the interface of an antibody B2212A and its antigen roundabout homolog 1
Yui, A., Akiba, H., Kudo, S., Nakakido, M., Nagatoishi, S., & Tsumoto, K. (2017) · The Journal of Biochemistry · doi:10.1093/jb/mvx050 · Cited by 3
Structure-Based Antibody Paratope Prediction with 3D Zernike Descriptors and SVM
Daberdaku, S. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-34585-3_4 · Cited by 3
An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy
Abdolmaleki, S., Ganjalıkhani-Hakemi, M., & Ganjalikhany, M. R. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304270 · Cited by 4
Multimodal diffusion for joint design of protein sequence and structure
Zhu, S., Gulati, S., Liu, Y., Kotnis, S., Sun, Q. H., & Shen, Y. (2025) · Protein Science · doi:10.1002/pro.70340 · Cited by 5
hAb-Convergent: an antibody rearrangement analysis system for therapeutic antibody engineering based on convergent evolution
Wang, J., Ge, X., Sun, Q., Chen, M., Qin, S., Liu, D., Deng, T., Ma, J., Hu, S., Jin, R., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf407 · Cited by 2
Structural insights into the rational design of a nanobody that binds with high affinity to the SARS-CoV-2 spike variant
Yamaguchi, K., Anzai, I., Maeda, R., Moriguchi, M., Watanabe, T., Imura, A., Takaori‐Kondo, A., & Tsuyoshi Inoue, A. (2022) · The Journal of Biochemistry · doi:10.1093/jb/mvac096 · Cited by 2
Analysis of fast boundary-integral approximations for modeling electrostatic contributions of molecular binding
Kreienkamp, A., Liu, L., Minkara, M. S., Knepley, M. G., Bardhan, J. P., & Radhakrishnan, M. L. (2013) · Computational and Mathematical Biophysics · doi:10.2478/mlbmb-2013-0007 · Cited by 2
Optimisation of human VH domain antibodies specific to Mycobacterium tuberculosis heat shock protein (HSP16.3)
Soong, J. X., Chan, S. K., Lim, T. S., & Choong, Y. S. (2019) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-019-00186-z · Cited by 3
Analytic modeling of antibody versus nanocell delivery of photosensitizer
Pogue, B. W., Srinivasan, S., Samkoe, K. S., Zheng, L. Z., Rai, P., Mai, Z., Verma, S., & Hasan, T. G. (2010) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.853925 · Cited by 2
Systems Approach to Therapeutics Design
Lao, B. J., & Kamei, D. T. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-525-1_8 · Cited by 2
Binding affinity optimization and structural evaluation of designed antibodies against PD-1 and PD-L1 as critical immune checkpoints involved in cancer treatmentPreprint
Abdolmaleki, S., Ganjalıkhani-Hakemi, M., & Ganjalikhany, M. R. (2024) · Research Square · doi:10.21203/rs.3.rs-3837879/v1 · Cited by 2
Enhancing affinity of neutralizing SARS-CoV-2 nanobody through facile structure-guided mutations in CDRsPreprint
Singh, V., Bhutkar, M., Choudhary, S., Nehul, S., Kumar, R., Singla, J., Kumar, P., & Tomar, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.13.593833 · Cited by 2
Variable chain engineering – humanization and optimization approaches
(2012) · Elsevier eBooks · doi:10.1533/9781908818096.111 · Cited by 1
A modular platform for Sterically Masked Activated Cytokines (SMACks)
Morgenstern, T. J., Ota, N., Lin, Z., Lechermann, L. M., Gill, H. S., Ogasawara, A. K., Williams, S., Marroquin, K. A., Scherl, A., Davies, C., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2513720123 · Cited by 1

Authors: Lippow, S. M., Wittrup, K. D., & Tidor, B.
Affiliations: Massachusetts Institute of Technology (US)
Corresponding author: Wittrup, K Dane
Tidor, Bruce
ORCID: Wittrup, K Dane
Tidor, Bruce
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2007-09-23
Volume: 25
Issue: 10
Pages: 1171-1176
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/nbt1336
PMC: PMC2803018
OpenAlex: W2083028331
Cited by: 342
References: 30
Citations by year: 2026: 9 · 2025: 11 · 2024: 14 · 2023: 17 · 2022: 24 · 2021: 14 · 2020: 22 · 2019: 15 · 2018: 23 · 2017: 18 · 2016: 15 · 2015: 24 · 2014: 23 · 2013: 21 · 2012: 21
FWCI: 14.05
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Science Foundation
National Institutes of Health
National Cancer Institute (CA96504, R01CA096504)
National Institute of General Medical Sciences (GM65418, R56GM065418, R01GM065418)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords: affinity maturation, computational antibody design, point mutations, cetuximab, anti-EGFR monoclonal antibody, bevacizumab, anti-fluorescein antibody, anti-lysozyme antibody, therapeutic antibodies, directed evolution, binding affinity enhancement
MeSH terms: Antibodies, Antibody Affinity, Antigens, Genetic Engineering, Models, Biological, Models, Molecular, Muramidase, Mutation, Protein Binding, Protein Conformation, Yeasts, Computer-Aided Design

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Computational design of antibody-affinity improvement beyond in vivo maturation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks